APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-invasive Tumor Detection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Non-invasive Tumor Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 May 2026185 pages

Choose your research edition.

Industry ResearchNon-invasive Tumor Detection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-invasive Tumor Detection Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Non-invasive Tumor Detection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-invasive Tumor Detection Market Outlook and Growth Opportunities 2026185 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-invasive Tumor Detection Market Analysis and Forecast 2026-2032235 pages · $4,950 USD

Market perspective

The global Non-invasive Tumor Detection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Non-invasive Tumor Detection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Non-invasive Tumor Detection include Datar Cancer Genetics, Nucleix, bioAffinity Technologies, miR Scientific, Nonacus, Natera and Penn Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Non-invasive Tumor Detection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-invasive Tumor Detection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-invasive Tumor Detection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Non-invasive Tumor Detection market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-invasive Tumor Detection Segment by Company

Datar Cancer Genetics

Nucleix

bioAffinity Technologies

miR Scientific

Nonacus

Natera

Penn Medicine

Non-invasive Tumor Detection Segment by Type

DNA

RNA

Non-invasive Tumor Detection Segment by Application

Prostate Cancer

Bladder Cancer

Pancreatic Cancer

Breast Cancer

Gastric Cancer

Others

Non-invasive Tumor Detection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Tumor Detection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Tumor Detection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Tumor Detection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Non-invasive Tumor Detection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-invasive Tumor Detection industry.

Chapter 3: Detailed analysis of Non-invasive Tumor Detection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-invasive Tumor Detectionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-invasive Tumor Detection Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of DNA Table 3. Key Players of RNA Table 4. Global Non-invasive Tumor Detection Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Prostate Cancer Table 6. Key Players of Bladder Cancer Table 7. Key Players of Pancreatic Cancer Table 8. Key Players of Breast Cancer Table 9. Key Players of Gastric Cancer Table 10. Key Players of Others Table 11. Global Non-invasive Tumor Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Non-invasive Tumor Detection Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Non-invasive Tumor Detection Market Share by Region (2021-2026) Table 14. Global Non-invasive Tumor Detection Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Non-invasive Tumor Detection Market Share by Region (2027-2032) Table 16. Non-invasive Tumor Detection Industry Trends Table 17. Non-invasive Tumor Detection Industry Drivers Table 18. Non-invasive Tumor Detection Industry Opportunities and Challenges Table 19. Non-invasive Tumor Detection Industry Restraints Table 20. Global Non-invasive Tumor Detection Revenue by Company (US$ Million) & (2021-2026) Table 21. Global Non-invasive Tumor Detection Revenue Market Share by Company (2021-2026) Table 22. Global Non-invasive Tumor Detection Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 23. Global Non-invasive Tumor Detection Key Company Head Office and Area Served Table 24. Global Non-invasive Tumor Detection Company, Product Type & Application Table 25. Global Non-invasive Tumor Detection Company Establishment Date Table 26. Global Company Market Concentration Ratio (CR5 and HHI) Table 27. Global Non-invasive Tumor Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 28. Global Non-invasive Tumor Detection Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Non-invasive Tumor Detection Market Size by Type (2021-2026) & (US$ Million) Table 30. Global Non-invasive Tumor Detection Market Size by Type (2027-2032) & (US$ Million) Table 31. Global Non-invasive Tumor Detection Revenue Market Share by Type (2021-2026) Table 32. Global Non-invasive Tumor Detection Revenue Market Share by Type (2027-2032) Table 33. Global Non-invasive Tumor Detection Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Non-invasive Tumor Detection Market Size by Application (2021-2026) & (US$ Million) Table 35. Global Non-invasive Tumor Detection Market Size by Application (2027-2032) & (US$ Million) Table 36. Global Non-invasive Tumor Detection Revenue Market Share by Application (2021-2026) Table 37. Global Non-invasive Tumor Detection Revenue Market Share by Application (2027-2032) Table 38. Datar Cancer Genetics Company Information Table 39. Datar Cancer Genetics Business Overview Table 40. Datar Cancer Genetics Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Datar Cancer Genetics Non-invasive Tumor Detection Product Portfolio Table 42. Datar Cancer Genetics Recent Development Table 43. Nucleix Company Information Table 44. Nucleix Business Overview Table 45. Nucleix Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Nucleix Non-invasive Tumor Detection Product Portfolio Table 47. Nucleix Recent Development Table 48. bioAffinity Technologies Company Information Table 49. bioAffinity Technologies Business Overview Table 50. bioAffinity Technologies Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. bioAffinity Technologies Non-invasive Tumor Detection Product Portfolio Table 52. bioAffinity Technologies Recent Development Table 53. miR Scientific Company Information Table 54. miR Scientific Business Overview Table 55. miR Scientific Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. miR Scientific Non-invasive Tumor Detection Product Portfolio Table 57. miR Scientific Recent Development Table 58. Nonacus Company Information Table 59. Nonacus Business Overview Table 60. Nonacus Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Nonacus Non-invasive Tumor Detection Product Portfolio Table 62. Nonacus Recent Development Table 63. Natera Company Information Table 64. Natera Business Overview Table 65. Natera Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Natera Non-invasive Tumor Detection Product Portfolio Table 67. Natera Recent Development Table 68. Penn Medicine Company Information Table 69. Penn Medicine Business Overview Table 70. Penn Medicine Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Penn Medicine Non-invasive Tumor Detection Product Portfolio Table 72. Penn Medicine Recent Development Table 73. North America Non-invasive Tumor Detection Market Size by Type (2021-2026) & (US$ Million) Table 74. North America Non-invasive Tumor Detection Market Size by Type (2027-2032) & (US$ Million) Table 75. North America Non-invasive Tumor Detection Market Size by Application (2021-2026) & (US$ Million) Table 76. North America Non-invasive Tumor Detection Market Size by Application (2027-2032) & (US$ Million) Table 77. North America Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 78. North America Non-invasive Tumor Detection Market Size by Country (2021-2026) Table 79. North America Non-invasive Tumor Detection Market Size by Country (2027-2032) Table 80. Europe Non-invasive Tumor Detection Market Size by Type (2021-2026) & (US$ Million) Table 81. Europe Non-invasive Tumor Detection Market Size by Type (2027-2032) & (US$ Million) Table 82. Europe Non-invasive Tumor Detection Market Size by Application (2021-2026) & (US$ Million) Table 83. Europe Non-invasive Tumor Detection Market Size by Application (2027-2032) & (US$ Million) Table 84. Europe Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. Europe Non-invasive Tumor Detection Market Size by Country (2021-2026) Table 86. Europe Non-invasive Tumor Detection Market Size by Country (2027-2032) Table 87. China Non-invasive Tumor Detection Market Size by Type (2021-2026) & (US$ Million) Table 88. China Non-invasive Tumor Detection Market Size by Type (2027-2032) & (US$ Million) Table 89. China Non-invasive Tumor Detection Market Size by Application (2021-2026) & (US$ Million) Table 90. China Non-invasive Tumor Detection Market Size by Application (2027-2032) & (US$ Million) Table 91. Asia Non-invasive Tumor Detection Market Size by Type (2021-2026) & (US$ Million) Table 92. Asia Non-invasive Tumor Detection Market Size by Type (2027-2032) & (US$ Million) Table 93. Asia Non-invasive Tumor Detection Market Size by Application (2021-2026) & (US$ Million) Table 94. Asia Non-invasive Tumor Detection Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. Asia Non-invasive Tumor Detection Market Size by Country (2021-2026) Table 97. Asia Non-invasive Tumor Detection Market Size by Country (2027-2032) Table 98. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Type (2021-2026) & (US$ Million) Table 99. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Type (2027-2032) & (US$ Million) Table 100. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Application (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Application (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2021-2026) Table 104. South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2027-2032) Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Non-invasive Tumor Detection Product Image Figure 2. Global Non-invasive Tumor Detection Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Non-invasive Tumor Detection Market Share by Type: 2025 VS 2032 Figure 4. DNA Image Figure 5. RNA Image Figure 6. Global Non-invasive Tumor Detection Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Non-invasive Tumor Detection Market Share by Application: 2025 VS 2032 Figure 8. Prostate Cancer Image Figure 9. Bladder Cancer Image Figure 10. Pancreatic Cancer Image Figure 11. Breast Cancer Image Figure 12. Gastric Cancer Image Figure 13. Others Image Figure 14. Global Non-invasive Tumor Detection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 16. Global Non-invasive Tumor Detection Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Non-invasive Tumor Detection Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Non-invasive Tumor Detection Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Non-invasive Tumor Detection Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Non-invasive Tumor Detection Revenue Market Share by Type (2021-2032) Figure 23. Global Non-invasive Tumor Detection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Non-invasive Tumor Detection Revenue Market Share by Application (2021-2032) Figure 25. North America Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 26. North America Non-invasive Tumor Detection Market Share by Type (2021-2032) Figure 27. North America Non-invasive Tumor Detection Market Share by Application (2021-2032) Figure 28. North America Non-invasive Tumor Detection Market Share by Country (2021-2032) Figure 29. United States Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 30. Canada Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 32. Europe Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 33. Europe Non-invasive Tumor Detection Market Share by Type (2021-2032) Figure 34. Europe Non-invasive Tumor Detection Market Share by Application (2021-2032) Figure 35. Europe Non-invasive Tumor Detection Market Share by Country (2021-2032) Figure 36. Germany Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 37. France Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 39. Italy Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 40. Russia Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 42. China Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 43. China Non-invasive Tumor Detection Market Share by Type (2021-2032) Figure 44. China Non-invasive Tumor Detection Market Share by Application (2021-2032) Figure 45. Asia Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 46. Asia Non-invasive Tumor Detection Market Share by Type (2021-2032) Figure 47. Asia Non-invasive Tumor Detection Market Share by Application (2021-2032) Figure 48. Asia Non-invasive Tumor Detection Market Share by Country (2021-2032) Figure 49. Japan Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 53. India Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 54. Australia Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Non-invasive Tumor Detection Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Non-invasive Tumor Detection Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Non-invasive Tumor Detection Market Share by Country (2021-2032) Figure 59. Brazil Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 64. UAE Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 66. Chile Non-invasive Tumor Detection Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • DNA
  • RNA
Applications
  • Prostate Cancer
  • Bladder Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Gastric Cancer
  • Others
Companies covered
  • Datar Cancer Genetics
  • Nucleix
  • bioAffinity Technologies
  • miR Scientific
  • Nonacus
  • Natera
  • Penn Medicine

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Non-invasive Tumor Detection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 DNA
  5. 1.2.3 RNA
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Non-invasive Tumor Detection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Prostate Cancer
  9. 1.3.3 Bladder Cancer
  10. 1.3.4 Pancreatic Cancer
  11. 1.3.5 Breast Cancer
  12. 1.3.6 Gastric Cancer
  13. 1.3.7 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Non-invasive Tumor Detection Growth Trends by Region
  16. 1.5.1 Global Non-invasive Tumor Detection Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Non-invasive Tumor Detection Market Size by Region (2021-2026)
  18. 1.5.3 Non-invasive Tumor Detection Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Non-invasive Tumor Detection Market Dynamics
  1. 2.1 Non-invasive Tumor Detection Industry Trends
  2. 2.2 Non-invasive Tumor Detection Industry Drivers
  3. 2.3 Non-invasive Tumor Detection Industry Opportunities and Challenges
  4. 2.4 Non-invasive Tumor Detection Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Non-invasive Tumor Detection Revenue by Company (2021-2026)
  2. 3.2 Global Non-invasive Tumor Detection Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Non-invasive Tumor Detection Key Company Head office and Area Served
  4. 3.4 Global Non-invasive Tumor Detection Company, Product Type & Application
  5. 3.5 Global Non-invasive Tumor Detection Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Non-invasive Tumor Detection Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Non-invasive Tumor Detection Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Non-invasive Tumor Detection Tier 1, Tier 2, and Tier 3
4 Non-invasive Tumor Detection Market by Type
  1. 4.1 Global Non-invasive Tumor Detection Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Non-invasive Tumor Detection Market Size by Type (2021-2032)
  3. 4.3 Global Non-invasive Tumor Detection Market Size Share by Type (2021-2032)
5 Non-invasive Tumor Detection Market by Application
  1. 5.1 Global Non-invasive Tumor Detection Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-invasive Tumor Detection Market Size by Application (2021-2032)
  3. 5.3 Global Non-invasive Tumor Detection Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Datar Cancer Genetics
  2. 6.1.1 Datar Cancer Genetics Company Information
  3. 6.1.2 Datar Cancer Genetics Business Overview
  4. 6.1.3 Datar Cancer Genetics Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Datar Cancer Genetics Non-invasive Tumor Detection Product Portfolio
  6. 6.1.5 Datar Cancer Genetics Recent Developments
  7. 6.2 Nucleix
  8. 6.2.1 Nucleix Company Information
  9. 6.2.2 Nucleix Business Overview
  10. 6.2.3 Nucleix Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Nucleix Non-invasive Tumor Detection Product Portfolio
  12. 6.2.5 Nucleix Recent Developments
  13. 6.3 bioAffinity Technologies
  14. 6.3.1 bioAffinity Technologies Company Information
  15. 6.3.2 bioAffinity Technologies Business Overview
  16. 6.3.3 bioAffinity Technologies Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 bioAffinity Technologies Non-invasive Tumor Detection Product Portfolio
  18. 6.3.5 bioAffinity Technologies Recent Developments
  19. 6.4 miR Scientific
  20. 6.4.1 miR Scientific Company Information
  21. 6.4.2 miR Scientific Business Overview
  22. 6.4.3 miR Scientific Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 miR Scientific Non-invasive Tumor Detection Product Portfolio
  24. 6.4.5 miR Scientific Recent Developments
  25. 6.5 Nonacus
  26. 6.5.1 Nonacus Company Information
  27. 6.5.2 Nonacus Business Overview
  28. 6.5.3 Nonacus Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Nonacus Non-invasive Tumor Detection Product Portfolio
  30. 6.5.5 Nonacus Recent Developments
  31. 6.6 Natera
  32. 6.6.1 Natera Company Information
  33. 6.6.2 Natera Business Overview
  34. 6.6.3 Natera Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Natera Non-invasive Tumor Detection Product Portfolio
  36. 6.6.5 Natera Recent Developments
  37. 6.7 Penn Medicine
  38. 6.7.1 Penn Medicine Company Information
  39. 6.7.2 Penn Medicine Business Overview
  40. 6.7.3 Penn Medicine Non-invasive Tumor Detection Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Penn Medicine Non-invasive Tumor Detection Product Portfolio
  42. 6.7.5 Penn Medicine Recent Developments
7 North America
  1. 7.1 North America Non-invasive Tumor Detection Market Size (2021-2032)
  2. 7.2 North America Non-invasive Tumor Detection Market Size by Type
  3. 7.2.1 North America Non-invasive Tumor Detection Market Size by Type (2021-2026)
  4. 7.2.2 North America Non-invasive Tumor Detection Market Size by Type (2027-2032)
  5. 7.2.3 North America Non-invasive Tumor Detection Market Share by Type (2021-2032)
  6. 7.3 North America Non-invasive Tumor Detection Market Size by Application
  7. 7.3.1 North America Non-invasive Tumor Detection Market Size by Application (2021-2026)
  8. 7.3.2 North America Non-invasive Tumor Detection Market Size by Application (2027-2032)
  9. 7.3.3 North America Non-invasive Tumor Detection Market Share by Application (2021-2032)
  10. 7.4 North America Non-invasive Tumor Detection Market Size by Country
  11. 7.4.1 North America Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Non-invasive Tumor Detection Market Size by Country (2021-2026)
  13. 7.4.3 North America Non-invasive Tumor Detection Market Size by Country (2027-2032)
  14. 7.4.4 North America Non-invasive Tumor Detection Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Non-invasive Tumor Detection Market Size (2021-2032)
  2. 8.2 Europe Non-invasive Tumor Detection Market Size by Type
  3. 8.2.1 Europe Non-invasive Tumor Detection Market Size by Type (2021-2026)
  4. 8.2.2 Europe Non-invasive Tumor Detection Market Size by Type (2027-2032)
  5. 8.2.3 Europe Non-invasive Tumor Detection Market Share by Type (2021-2032)
  6. 8.3 Europe Non-invasive Tumor Detection Market Size by Application
  7. 8.3.1 Europe Non-invasive Tumor Detection Market Size by Application (2021-2026)
  8. 8.3.2 Europe Non-invasive Tumor Detection Market Size by Application (2027-2032)
  9. 8.3.3 Europe Non-invasive Tumor Detection Market Share by Application (2021-2032)
  10. 8.4 Europe Non-invasive Tumor Detection Market Size by Country
  11. 8.4.1 Europe Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Non-invasive Tumor Detection Market Size by Country (2021-2026)
  13. 8.4.3 Europe Non-invasive Tumor Detection Market Size by Country (2027-2032)
  14. 8.4.4 Europe Non-invasive Tumor Detection Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Non-invasive Tumor Detection Market Size (2021-2032)
  2. 9.2 China Non-invasive Tumor Detection Market Size by Type
  3. 9.2.1 China Non-invasive Tumor Detection Market Size by Type (2021-2026)
  4. 9.2.2 China Non-invasive Tumor Detection Market Size by Type (2027-2032)
  5. 9.2.3 China Non-invasive Tumor Detection Market Share by Type (2021-2032)
  6. 9.3 China Non-invasive Tumor Detection Market Size by Application
  7. 9.3.1 China Non-invasive Tumor Detection Market Size by Application (2021-2026)
  8. 9.3.2 China Non-invasive Tumor Detection Market Size by Application (2027-2032)
  9. 9.3.3 China Non-invasive Tumor Detection Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Non-invasive Tumor Detection Market Size (2021-2032)
  2. 10.2 Asia Non-invasive Tumor Detection Market Size by Type
  3. 10.2.1 Asia Non-invasive Tumor Detection Market Size by Type (2021-2026)
  4. 10.2.2 Asia Non-invasive Tumor Detection Market Size by Type (2027-2032)
  5. 10.2.3 Asia Non-invasive Tumor Detection Market Share by Type (2021-2032)
  6. 10.3 Asia Non-invasive Tumor Detection Market Size by Application
  7. 10.3.1 Asia Non-invasive Tumor Detection Market Size by Application (2021-2026)
  8. 10.3.2 Asia Non-invasive Tumor Detection Market Size by Application (2027-2032)
  9. 10.3.3 Asia Non-invasive Tumor Detection Market Share by Application (2021-2032)
  10. 10.4 Asia Non-invasive Tumor Detection Market Size by Country
  11. 10.4.1 Asia Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Non-invasive Tumor Detection Market Size by Country (2021-2026)
  13. 10.4.3 Asia Non-invasive Tumor Detection Market Size by Country (2027-2032)
  14. 10.4.4 Asia Non-invasive Tumor Detection Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Non-invasive Tumor Detection Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Non-invasive Tumor Detection Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Non-invasive Tumor Detection Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Non-invasive Tumor Detection Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Non-invasive Tumor Detection Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst